NCT00000240
Completed
Phase 2
Combined Buprenorphine and Behavioral Treatment Without Contingent Reinforcement
Overview
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- University of Vermont
- Locations
- 1
- Primary Endpoint
- Drug use
Overview
Brief Summary
The purpose of this study is to test combined buprenorphine and behavioral treatment with and without contingent reinforcement on opioid and cocaine abstinence.
Study Design
- Study Type
- Interventional
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 23 Years to 47 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Drug use
Retention
Weeks abstinent
Weeks continuous abstinence
Overall treatment outcome
Opioid dependence and psychiatric status
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12Opioid-Related DisordersNCT00000230University of Vermont
Completed
Phase 2
Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13Opioid-Related DisordersNCT00000231National Institute on Drug Abuse (NIDA)
Completed
Phase 2
Combined Pharmaco/Behavior Therapy in Adolescent SmokersNicotine DependenceNicotine Use DisorderNCT00330187Medical University of South Carolina134
Completed
Phase 2
Integrated Treatment for Cocaine and Mood Disorders - 1Cocaine DependenceDepressive Disorder, MajorNCT00227812National Institute on Drug Abuse (NIDA)140
Completed
Phase 3
The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.OsteoarthritisNCT00315848Purdue Pharma LP225